Summary
Lipoprotein(a), as an atherogenic particle, represents an independent risk factor for coronary heart disease. In the present study the morphological distribution of apoprotein (a) and apoprotein B within the arterial wall is described. Apoprotein B, a constituent of very low-density lipoprotein, low-density lipoprotein and lipoprotein(a) has previously been demonstrated in atheromatous lesions. Lipoprotein(a) possesses an additional protein, designated apoprotein (a). Autopsy material (n=74) from the left coronary artery and from the thoracic aorta has been examined by means of immunohistochemistry and both apoprotein (a) and apoprotein B were detected, primarily associated with the extracellular matrix and accumulating in lesions in the arterial wall. The staining pattern for both antigens was almost always found to be congruent, suggesting that the detection of (a)-antigen has to be attributed at least in part to the presence of lipoprotein(a). It is concluded that both low-density lipoprotein and lipoprotein(a) have an important role in the pathogenesis of atherosclerosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Armstrong VW, Walli AK, Seidel D (1985) Isolation, characterization, and uptake in human fibroblasts of an Apo(a)-free lipoprotein obtained on reduction of lipoprotein(a). J Lipid Res 26:1314–1323
Armstrong VW, Cremer P, Eberle E, Manke A, Schulze F, Wieland H, Kreuzer H, Seidel D (1986) The association between serum Lp(a) concentrations and angiographically assessed coronary atherosclerosis: dependence on serum LDL levels. Atherosclerosis 62:249–257
Berg KA (1963) New serum type system in man — the Lp system. Acta Pathol 59:369–382
Blumberg BS, Bernanke D, Allison AC (1962) A human lipoprotein polymorphism. J Clin Invest 41:1936–1944
Carter RS, Siegel RJ, Chai AU, Fishbein MC (1987) Immunohistochemical localization of apolipoproteins A-I and B in human carotid arteries. J Pathol 153:31–36
Dahlen G, Guyton JR, Attar M, Farmer JA, Kautz JA, Gotto AM jr. (1986) Association of levels of lipoprotein(a) (Lp(a)), plasma lipids and other lipoproteins with coronary artery disease documented by angiography. Circulation 74:758–765
Eaton DL, Fless GM, Kohr WJ, Mc Lean JW, Xu QT, Miller CB, Lawn RM, Scann AM (1987) Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen. Proc Natl Acad Sci USA 84:3224–3228
Ehnholm C, Groff H, Renkonen O, Simons K (1972) Protein and carbohydrate composition of Lp(a) lipoprotein from human plasma. Biochemistry 11:3220–3232
Floren CH, Albers JJ, Biermann EL (1981) Uptake of Lp(a) by cultured fibroblasts. Biochem Biophys Res Commun 102:636–639
Havekes L, Vermeer BJ, Brugmann T, Emeis J (1981) Binding of Lp(a) to the low density lipoprotein receptor of human fibroblasts. FEBS Lett 132:169–173
Hoff HF, Bond MG (1983) Apolipoprotein B localization in coronary atherosclerotic plaques from cynomolgus monkeys. Artery 12:104–116
Hoff HF, Heidemann CL, Gotto AM, Gaubatz JW (1977) Apolipoprotein B retention in the grossly normal and atherosclerotic human aorta. Circ Res 41:684–690
Hoff HF, Heidemann CI, Gaubatz JW, Scott DW, Titus JL, Gotto AM (1978) Correlation of apolipoprotein B retention with the structure of atherosclerotic placques. Lab Invest 38:560
Hoff HF, Karagas M, Heidemann CL, Gaubatz JW, Gotto AM (1979) Correlation in the human aorta of ApoB fraction with tissue cholesterol and collagen content. Atherosclerosis 32:259–268
Hollander W, Paddock J, Colombo M (1979) Lipoproteins in human atherosclerotic vessels. Exp Mol Pathol 30:144–171
Hsu SM, Reine L, Fanger H (1981) Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabelled antibody (PAP) procedures. J Histochem Cytochem 29:577–580
Kratzin H, Armstrong VW, Niehaus M, Hilschmann N, Seidel D (1987) Structural relationship of an apolipoprotein(a) phenotype (570 kDa) to plasminogen: homologous kringle domain are linked by carbohydrate-rich regions. Biol Chem Hoppe-Seyler 368:1533–1544
Krempler F, Kostner GM, Roscher A, Bolzano K, Sandhofer F (1984) The interaction of human ApoB — containing cipoproteins with mouse peritoneal macrophages: a comparison of Lp(a) with LDL. J Lipid Res 25:283–287
Maartmann-Moe K, Berg K (1981) Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor. Clin Genet 20:352–362
McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM (1987) cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 300:132–137
Niendorf A, Arps H, Sieck M, Dietel M (1987) Immunoreactivity of PTH-binding in intact bovine kidney tissue and cultured cortical kidney cells indicative for specific receptors. Acta Endocrinol (Copenh) 281:207–211
Rath M, Niendorf A, Reblin T, Dietel M, Krebber J, Beisiegel U (1989) Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients. Arteriosclerosis 9:579–592
Schriewer H, Assmann G, Sandkamp M (1984) The relationship of lipoprotein(a) (Lp(a)) to risk factors of coronary heart disease. J Clin Chem Clin Biochem 22:591–596
Simons K, Ehnholm C, Renkonen O, Bloth B (1970) Characterization of the Lp(a) lipoprotein in human plasma. Acta Pathol Microbiol Scand B 78:459–466
Smith EB, Slater RS (1972) Relationship between low-density lipoprotein in aortic intima and serum-lipid levels. Lancet I:463–469
Smith EB, Massie IB, Alexander KM (1976) The release of an immobilized lipoprotein fraction from atherosclerotic lesions by incubation with plasmin. Atherosclerosis 25:71–84
Utermann G, Wiegandt H (1969) Darstellung und Charakterisierung eines Lipoproteins mit Antigenwirksamkeit mit LP-System. Humangenetik 8:47–52
Utermann G, Menzel HJ, Kraft HG, Duba HC, Kemmler HG, Seitz C (1978) Lp(a) glycoproteins phenotypes. J Clin Invest 80:458–465
Walton KW, Hitchens J, Magnani AL, Khan M (1974) A study of methods of identification and estimation of Lp(a) lipoprotein and of its significance in health, hyperlipidemia and atherosclerosis. Atherosclerosis 20:323–346
Wottawa A, Fromme K, Klein G (1984) Lipoprotein(a) bei coronarer Herzkrankheit und Myokardinfarkt. MMW 3:53–55
Yamauchi J, Hoff HF (1984) Apolipoprotein B Accumulation and development of foam cell lesions in coronary arteries of hypercholesterolemic swine. Lab Invest 51:325–332
Ylä-Herttuala S, Jaakkola O, Ehnholm C, Tikkanen MJ, Solakioi T, Särkoja T, Nikkari T (1988) Characterization of two lipoproteins containing apolipoproteins B and E from lesionfree human aortic intima. J Lipid Res 29:563–572
Yomantas S, Elner VM, Schaffner T, Wissler RW (1984) Immunohistochemical localization of apolipoprotein B in human atherosclerotic lesions. Arch Pathol Lab Med 108:374–378
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Niendorf, A., Rath, M., Wolf, K. et al. Morphological detection and quantification of lipoprotein(a) deposition in atheromatous lesions of human aorta and coronary arteries. Vichows Archiv A Pathol Anat 417, 105–111 (1990). https://doi.org/10.1007/BF02190527
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02190527